
Vumerity (diroximel fumarate) approved for relapsing remitting MS in England and Wales The MS Trust have recently reported that Vumerity (diroximel fumarate) has been approved by NICE (National Institute for Health and Care Excellence) for people with active relapsing remitting multiple sclerosis. NICE has recommended that Vumerity can be prescribed as a twice daily tablet for people with relapsing… Read more »